CCMG
IBB icon

Clark Capital Management Group’s iShares Biotechnology ETF IBB Stock Holding History

Clark Capital Management Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Sell
6,979
-8,523
-55% -$1.46M 0.01% 311
2026
Q1 		$2.62M Buy
15,502
+4,181
+37% +$715K 0.02% 260
2025
Q4 		$1.91M Buy
+11,321
New +$1.84M 0.01% 267
2023
Q1 		– Sell
-62,689
Closed -$8.23M – 349
2022
Q4 		$8.23M Buy
62,689
+26,282
+72% +$3.4M 0.08% 158
2022
Q3 		$4.26M Buy
+36,407
New +$4.52M 0.06% 171
2020
Q1 		– Sell
-14,347
Closed -$1.73M – 297
2019
Q4 		$1.73M Buy
+14,347
New +$1.6M 0.04% 197
2017
Q4 		– Sell
-32,496
Closed -$3.61M – 300
2017
Q3 		$3.61M Buy
+32,496
New +$3.47M 0.12% 125
2015
Q4 		– Sell
-60,507
Closed -$6.12M – 317
2015
Q3 		$6.12M Buy
60,507
+22,302
+58% +$2.68M 0.55% 57
2015
Q2 		$4.7M Sell
38,205
-3,282
-8% -$393K 0.43% 71
2015
Q1 		$4.75M Sell
41,487
-6,759
-14% -$745K 0.43% 70
2014
Q4 		$4.88M Sell
48,246
-14,799
-23% -$1.44M 0.45% 67
2014
Q3 		$5.75M Sell
63,045
-10,014
-14% -$879K 0.5% 61
2014
Q2 		$6.26M Sell
73,059
-3,366
-4% -$265K 0.52% 55
2014
Q1 		$6.02M Sell
76,425
-15,507
-17% -$1.29M 0.52% 64
2013
Q4 		$6.96M Sell
91,932
-38,382
-29% -$2.72M 0.58% 43
2013
Q3 		$9.11M Buy
+130,314
New +$8.54M 0.72% 28

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Clark Capital Management Group's IBB Position: Q2 2026 in Review

Clark Capital Management Group reduced its iShares Biotechnology ETF (IBB) stake by 55% in Q2 2026, selling an estimated $1.46M and leaving 6,979 shares worth $1.33M. The position accounts for 0.01% of the portfolio, ranked #311.

Clark Capital Management Group first reported a position in IBB in Q3 2013 and has held it in 16 quarters since. The position peaked at $9.11M in Q3 2013. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Clark Capital Management Group held 6,979 shares of iShares Biotechnology ETF worth $1.33M as of Q2 2026.
  • Clark Capital Management Group sold 8,523 iShares Biotechnology ETF shares in Q2 2026, an estimated $1.46M.
  • iShares Biotechnology ETF made up 0.01% of Clark Capital Management Group's portfolio in Q2 2026, its #311 holding.
  • Clark Capital Management Group first reported a position in iShares Biotechnology ETF in Q3 2013 and has held it in 16 quarters since.
  • Clark Capital Management Group's iShares Biotechnology ETF position peaked at $9.11M in Q3 2013.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Clark Capital Management Group's 13F filing for Q2 2026, filed 11 Aug 2026.